CTRI/2023/09/057859尚未招募1 期
Clinical validation of safety and efficacy of herbal blends to alleviate stress and anxiety along with improved mood status in healthy individuals. - Nil
Sush Essentials Pvt. Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects meeting all of the following criteria will be eligible for the study:
- •1.Healthy male or female 25-55 years of age at the time of obtaining written informed consent
- •2.Subjects willing to sign inform consent form
- •3.A female participant who is of reproductive potential has a negative pregnancy test and agrees to use contraception throughout the study period
- •4.Subjects are free of anti-depressants /anti-anxiety/ mood enhancing/recreational drugs intake for at least one year at the start of the screening visit
- •5.Subjects are free of any ‘‘over the counter’’ or prescribed medications at the start of the screening visit
- •6.Subjects with a score of 7-26 on the Perceived Stress Scale (PSS)
- •7.Willing to abstain alcohol, caffeine, and nicotine consumption while in the study
- •8.No reported history of psychological or mental disorders.
- •9.Free of psychiatric conditions other than perceived stress
排除标准
- •Subjects meeting any of the following criteria will not be eligible for the study:
- •1.Resting systolic blood pressure above 140 mmHg or a diastolic blood pressure above 90 mmHg at baseline visit.
- •2.Taking any medicine or dietary supplements within the last 3 months to help to relieve sleep disturbances or physiological stress
- •3.History of substance abuse or dependence
- •4.Taking certain prohibited medications
- •5.Habitual smoking or vaping of products nicotine containing tetrahydrocannabinol (THC) with an average consumption >2 cigarettes or vaping more than 2 times per day
- •6.History of malignancy less than or equal to 5 years prior to signing an informed consent
- •7.Other conditions, which in the opinion of the investigators, makes the subject unsuitable for enrolment or could interfere with his/her participation in, and completion of the protocol.
- •8.Any known allergy or intolerance to any of the ingredients contained in supplements
研究者
相似试验
招募中
2 期
Study on herbal neutraceuticals in delivering physical energyCTRI/2023/02/049575MVR Ayurveda medical college and hospital
进行中(未招募)
不适用
Evaluation of efficacy and safety of the herbal drug Myrrhinil-Intest vs. mesalazine in maintaining clinical remission of ulcerative colitis - a 12-month, multicenter, randomized, prospective, double-blind, double-dummy, active-controlled and parallel group phase IV-trial - MIRCulcerative colitis patients in clinical remissionMedDRA version: 9.1Level: LLTClassification code 10045365Term: Ulcerative colitisEUCTR2007-007928-18-DEREPHA GmbH
进行中(未招募)
2 期
Clinical study on herbal neutraceuticals in stress managementCTRI/2022/09/045723MVR Ayurveda medical college and hospital
尚未招募
1 期
Amirdha Gandhi Kukil Vallathy - Siddha management for Uthira Vaatha Suronitham (Rheumatoid Arthritis)CTRI/2023/07/055008ot applicable
尚未招募
3 期
Evaluating the effectiveness of herbal toothpaste in the reduction of tooth debris and gum diseases in adultsCTRI/2024/02/062753Dabur Research & Development Centre
